The Case for Real-Time, Real-World Data
The landscape of wearable sensors in clinical trials has proven difficult to navigate for many, including sponsors and vendors.
Collaboration around the development of digital endpoints with a focus on data quality, validation, compliance, and clinical utility is required to extract the most from new digital technologies.
In this 20-minute presentation, VivoSense Cheif Science Officer, Kate Lyden, PhD., and Jeremy Wyatt, ActiGraph CEO, discuss:
- Characteristics of clinically meaningful endpoints
- The data behind developing a novel digital biomarker called the Best 6 Minute Effort (B6ME) an outcome assessment that can augment the in-clinic 6 Minute Walk Test (6MWT) with real-world data collected from a wearable sensor
- Steps for future development
Fill out the form to watch the presentation today!